Manila Times Business
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, June 01, 2026 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 18,600 restricted stock units ("RSUs”) to three newly-hired non-executive employees under the Company’s 2025 Inducement Equity Plan (the "Inducement Plan”), effective as of June 1, 2026. The inducement grants were previously approved by the Compensation Committee of the Company’s Board of Directors, as a material inducement to the new employees’ entry into
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
GameChange Energy to Vigorously Defend Patent Infringement Allegations by Nextpower
Just now
Tribeca Strategic Acquisition Corp. Announces Closing of $140,000,000 Initial Public Offering
Just now
Dime Commercial Bank To Ring Opening Bell at New York Stock Exchange
Just now
Rio Silver Announces Grant of Stock Options
Just now